1. Abitbol M, Puy H, Sabate JM, Guenet JL, Deybach JC, Montagutelli X. Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model. Physiol Res 55, Suppl 2: S93–S101, 2007.
2. Anderson KE, Sassa S, Bischop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: The Metabolic and Molecular Basis of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill, 2001, p. 2294–3062.
3. Review of Laboraotory and Clinical Studies of Olestra, a Nonabsorbable Lipid
4. Beukeveld GJJ, Nagel GT, de Ruyter-Buitenhuis AW, Kwarts EW, Wolthers BG. Determination of porphyrins in blood, urine and feaces by means of HPLC and its application in establising porphyrias. Biochimica Clinica 11: 203–213, 1987.
5. Bloks VW, Plosch T, Van Goor H, Roelofsen H, Baller J, Havinga R, Verkade HJ, van Tol A, Jansen PL, Kuipers F. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice. J Lipid Res 42: 41–50, 2001.